The exact pathomechanism of CRAO in dermatomyositis remains poorly elucidated and a prompt ophthalmological opinion/management is recommended to limit its progression. PubMed, Int J Rheum Dis, 09/25/2015. (Also see Symptoms/Complications of Dermatomyositis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.